Laloglu E. and Alay H. (2022) “Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR”, Upsala Journal of Medical Sciences, 127(1). doi: 10.48101/ujms.v127.8211.